Epazz, Inc. EPAZ Company Overview Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 2:35 PM

Epazz, Inc. EPAZ Company Overview

Stock Message Board http://investorshangout.com/search?q=EPAZ&...mp;yt1=Go!

Epazz, Inc. EPAZ Current Price and Quotes
Last Price 0.0012
Previous Close 0.0011 Open 0.0011
Daily Range 0.0012 - 0.001 52wk Range 0.0125 - 0.0006
Volume 1,822,954 Dividend N/A
Average Vol (3m) 16,252,398 Yield N/A
Epazz, Inc. EPAZ

Company Verified Profile
Company Information

309 W. Washington St.
Suite 1225
Chicago, IL 60606

Website: http://www.epazz.com
Phone: 312-955-8161
Find us on:

Epazz, Inc. EPAZ
Epazz Inc. is an enterprise-wide cloud software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology dema...

Epazz, Inc. EPAZ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001335239
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7372 - Prepackaged software
Business Status SPAC a/o Jun 18, 2008
Incorporated In: IL, USA
Year of Inc. 1999
Employees 8 a/o Mar 22, 2013
Company Officers/Contacts

Shaun Passley CEO, CFO, President
Company Directors

Shaun Passley Chairman
Service Providers

Auditor/Accountant
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Houston, TX, 77086
United States

Legal Counsel
The Loev Law Firm, PC
6300 West Loop South
Bellaire, TX, 77401
United States

Investor Relations Firm
QualityStocks.com
3370 N. Hayden Rd.
Scottsdale, AZ, 85251
United States

Epazz, Inc. EPAZ
EPAZ Security Details

Share Structure

Market Value1 $4,067,641 a/o Sep 13, 2013
Shares Outstanding 3,389,700,915 a/o Aug 16, 2013
Float 251,394,176 a/o Jul 10, 2013
Authorized Shares 6,000,000,000 a/o Jul 10, 2013
Par Value 0.01
Shareholders

Shareholders of Record 54 a/o Jul 10, 2013
Security Notes

Capital Change=shs decreased by 1 for 10 split. Pay date=08/24/2010.
Short Selling Data

Short Interest 104,760 (56.35%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Island Stock Transfer

Epazz, Inc. EPAZ Recent News

Sept 11, 2013 Epazz Stock Dividend: Epazz Filed Corporate Action With FINRA for ZFridge (Project Flex) Spin-Off; Record Date Set for September 15, 2013
Sept 10, 2013 Epazz Stock Dividend: Project Flex Official Name Is ZFridge; Spin-Off Record Date Set for September 15, 2013
Sept 9, 2013 Epazz Files Articles of Amendments on Its Subsidiaries as Part of Its Transition Plan to Become a Holding Company
Sept 4, 2013 Epazz Reaches Over 60 Million Shares on Short Sales Report for August 2013
Aug 27, 2013 Epazz Stock Dividend Reminder: Project Flex Spin-Off Record Date Set for September 15, 2013
Aug 14, 2013 Epazz Client Base Grows Over 500% in 3 Years
Aug 6, 2013 Epazz Advances Project Human Mobile Power Spinoff
Aug 1, 2013 Epazz Revenues up Over 1,000 Percent Since Going Public
Jul 30, 2013 Epazz Reaches Over 100 Million Shares on Short Sales Report for July 2013
Jul 26, 2013 OTC Daily Alert Stock Watch

1
2
next >

Epazz, Inc. EPAZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 1,193 736 705 360
Cost of Revenue - - - -
Gross Profit 1,193 736 705 360
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 2,364 637 405 327
Non-Recurring Items 3 82 - -
Other 275 177 106 35
Operating Income (1,449) (161) 194 (2)
Income From Continuing Operations

Add'l Income/Expense Items (137) - - -
Earnings Before Interest and Tax (1,586) (161) 194 (2)
Interest Expense 320 176 73 53
Earnings Before Tax (1,907) (337) 121 (55)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,907) (337) 121 (55)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,907) (337) 121 (55)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,907) (337) 121 (55)

EPAZ Epazz, Inc. Research DD Guide

EPAZ Epazz, Inc. Stock Message Board http://investorshangout.com/search?q=EPAZ&...mp;yt0=Go!
EPAZ Epazz, Inc. Stock Quote http://www.otcmarkets.com/stock/EPAZ/quote
EPAZ Epazz, Inc. Stock Chart http://www.otcmarkets.com/stock/EPAZ/chart
EPAZ Epazz, Inc. Company Info http://www.otcmarkets.com/stock/EPAZ/company-info
EPAZ Epazz, Inc. Recent News http://www.otcmarkets.com/stock/EPAZ/news
EPAZ Epazz, Inc. Financials http://www.otcmarkets.com/stock/EPAZ/financials
EPAZ Epazz, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/EPAZ/filings
EPAZ Epazz, Inc. Short Sales http://www.otcmarkets.com/stock/EPAZ/short-sales
EPAZ Epazz, Inc. Insider Disclosure http://www.otcmarkets.com/stock/EPAZ/insider-transactions
EPAZ Epazz, Inc. Research Reports http://www.otcmarkets.com/stock/EPAZ/research
EPAZ Epazz, Inc. Summary http://finance.yahoo.com/q?s=EPAZ
EPAZ Epazz, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=EPAZ+Historical+Prices
EPAZ Epazz, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=EPAZ
EPAZ Epazz, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=EPAZ+Basic+Chart
EPAZ Epazz, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EPAZ+Basic+Tech.+Analysis
EPAZ Epazz, Inc. Headlines http://finance.yahoo.com/q/h?s=EPAZ+Headlines
EPAZ Epazz, Inc. Press Releases http://finance.yahoo.com/q/p?s=EPAZ+Press+Releases
EPAZ Epazz, Inc. Company Profile http://finance.yahoo.com/q/pr?s=EPAZ+Profile
EPAZ Epazz, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=EPAZ+Key+Statistics
EPAZ Epazz, Inc. Industry http://finance.yahoo.com/q/in?s=EPAZ+Industry
EPAZ Epazz, Inc. Major Holders http://finance.yahoo.com/q/mh?s=EPAZ+Major+Holders
EPAZ Epazz, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=EPAZ+Insider+Transactions
EPAZ Epazz, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=EPAZ+Insider+Roster
EPAZ Epazz, Inc. Income Statement http://finance.yahoo.com/q/is?s=EPAZ
EPAZ Epazz, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=EPAZ
EPAZ Epazz, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=EPAZ+Cash+Flow&annual
EPAZ Epazz, Inc. Nasdaq http://www.nasdaq.com/symbol/EPAZ
EPAZ Epazz, Inc. Market Watch http://www.marketwatch.com/investing/stock/EPAZ
EPAZ Epazz, Inc. Bloomberg http://www.bloomberg.com/quote/EPAZ:US
EPAZ Epazz, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=EPAZ
EPAZ Epazz, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=EPAZ
EPAZ Epazz, Inc. Barchart http://www.barchart.com/quotes/stocks/EPAZ
EPAZ Epazz, Inc. OTC Short Report http://otcshortreport.com/index.php?index=EPAZ
EPAZ Epazz, Inc. Investopedia http://www.investopedia.com/markets/stocks/EPAZ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...